Top Defibrillator Companies Shaping the Market in 2025
16 May, 2025

The Defibrillator Market is anticipated to grow at a compound annual growth rate (CAGR) of 7.25% from 2025 to 2033, from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033. The rising incidence of cardiovascular disorders and improvements in medical technology are fueling the defibrillator market's notable expansion on a global scale. By reestablishing regular cardiac rhythms, defibrillators—such as wearable technology, implanted cardioverter defibrillators (ICDs), and automated external defibrillators (AEDs)—are essential in the treatment of sudden cardiac arrest. The industry has expanded even more quickly as a result of increased public awareness and laws requiring AEDs in public areas and educational institutions. Defibrillators are becoming more widely available and more efficient because to technological advancements such improved mobility and user-friendly designs. The Asia-Pacific region is anticipated to develop at the quickest rate due to rising healthcare investments and cardiovascular disease occurrences, while North America already has a sizable market share due to its sophisticated healthcare infrastructure and supporting legislation. Similarly, the Europe Defibrillator Market reached USD 3.87 billion in 2024 and is projected to rise at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033, reaching USD 7.23 billion.

The development of life-saving devices that restore normal heart rhythms during cardiac crises is the primary focus of companies in the defibrillator business. They spend money on research and development to improve the accuracy, portability, and use of their devices. Access and acceptance are increased in international markets through partnerships with healthcare professionals and public health campaigns.

Discover key trends, growth opportunities, and major challenges shaping the Defibrillator Industry in Renub Research’s latest in-depth market report. Download your free sample now

Global Leaders in Defibrillator Manufacturing

Medtronic Plc.

Establishment: 1949

Headquarters: Ireland

Website: www.medtronic.com

Revenue: $32.4B in 2023

The medical technology business Medtronic plc (Medtronic) creates, develops, produces, and sells medical equipment and solutions. Research, design, production, and sales of biomedical engineering products are among the company's primary endeavors. It provides products to treat heart valve problems, heart failure, aortic, peripheral vascular, venous, renal, and neurological illnesses, as well as disorders of the spine, musculoskeletal system, and the ears, nose, and throat. Additionally, Medtronic offers biologic solutions for the dentistry and orthopedic industries. In Asia Pacific, Europe, the Americas, the Middle East, and Africa, the firm sells its goods to hospitals, clinics, third-party healthcare providers, government healthcare programs, distributors, and group purchasing groups. The headquarters of Medtronic are located in Dublin, Ireland.

Boston Scientific Corporation

Establishment: 1979

Headquarters: United States of America

Website: www.bostonscientific.com/en-US/Home.html

Revenue: $16.7B in 2023

Athletic and sports lifestyle goods are designed, produced, and sold by adidas AG (adidas). The company's product line consists of clothing, shoes, and accessories including balls, backpacks, sunglasses, and exercise gear. Adidas distributes and sells its items through a number of channels, such as department shops, e-retailers, sports goods chains, own-branded stores, retail stores, wholesale stores, franchise stores, and buying groups. Additionally, it uses mobile shopping applications and e-commerce sites like adidas.co.in to market its goods. The adidas brand is used to sell its goods. The headquarters of adidas are located in Herzogenaurach, Bayern, Germany.

Philips Healthcare

Establishment: 1891

Headquarters: Netherlands

Website: www.philips.com

Revenue: $19.5B in 2023

Koninklijke Philips NV (Philips) is a multifaceted technology firm that creates and produces consumer electronics and medical solutions. Precision diagnostics, image-guided therapy, monitoring, enterprise informatics, sleep and respiratory care, and personal health are among the items that the firm sells. X-ray and fluoroscopy equipment, magnetic resonance imaging (MRI) equipment, computed tomography (CT) equipment, integrated interventional X-ray equipment, image guided therapy equipment, intracardiac echocardiography (ICE) equipment, hospital patient monitoring equipment, ambulatory monitoring and diagnostics equipment, battery-operated toothbrushes, brush heads, breast pumps, baby bottles, sterilizers, groomers, trimmers, and hair clippers are some of its main offerings. In Europe, North America, and Asia, the corporation provides services to healthcare practitioners, patients, and consumers in a variety of sectors. The Netherlands' Amsterdam, Noord-Holland, is home to Philips' headquarters.

Nihon Kohden Corporation

Establishment: 1951

Headquarters: Japan

Website: www.nihonkohden.co.jp

Revenue: $1.5B in 2023

Medical electronic equipment is developed, manufactured, and distributed by Nihon Kohden Corp. (Nihon Kohden). The main products of Nihon Kohden include a variety of medical devices, such as defibrillators, electrocardiographs, electroencephalographs, patient monitoring systems, and in-vitro diagnostic tools. The company's products are utilized in fundamental medical research, home medical care, nursing, emergency response, testing, diagnosis, treatment, and rehabilitation, among other clinical domains. Products from Nihon Kohden are sold all over the world, and the firm exports its medical gadgets and equipment to meet regional medical demands. A variety of foreign goods encompassing cardiology, urology, respiratory care, anesthesiology, emergency care, sports medicine, and rehabilitation are also imported into Japan by the corporation. Japan's Tokyo is home to Nihon Kohden's headquarters.

Asahi Kasei Corporation

Establishment: 1931

Headquarters: Japan

Website: www.asahi-kasei.co.jp

Revenue: $19.3B in 2023

Ralph Lauren Corp. (Ralph Lauren) creates, sells, and distributes high-end lifestyle goods, such as clothing, accessories, shoes, home furnishings, and perfumes. The company's product line comprises, among other things, clothing for men, women, and children, leather goods, purses, footwear, furniture, bedding, skincare products, and cosmetics. It sells these items under a number of different brands, such as Ralph Lauren, Chaps, Lauren, Pink Pony, Polo, and Purple Label. Additionally, Ralph offers hospitality services through Ralph's Coffee, RL Restaurant, and The Polo Bar. The business distributes its goods via department stores, specialty shops, wholesale, retail, third-party licensing, golf, and other channels. It has operations in Europe, Asia, North America, and other continents. The headquarters of Ralph Lauren are located in New York City, New York, USA.

Stryker Corporation

Establishment: 1941

Headquarters: United States of America

Website: www.stryker.com

Revenue: $22.6B in 2023

Stryker Corp. (Stryker) is a medical technology firm that manufactures spine, neurotechnology, orthopedic, and medical and surgical equipment. Orthopedic implants, surgical equipment and surgical navigation systems, endoscopic and communications systems, patient management, emergency medical equipment, and disposables for critical care are some of its main items. Additionally, it provides spinal, neurovascular, and neurosurgical equipment as well as medical gadgets for a range of ailments. Physicians, hospitals, and other healthcare organizations can purchase Stryker's goods. In the Americas, Europe, Asia-Pacific, the Middle East, and Africa, the corporation offers its goods through subsidiaries, branches, independent dealers, and distributors. The US city of Portage, Michigan, is home to Stryker's headquarters.

Abbott

Establishment: 1888

Headquarters: United States of America

Website: www.abbott.com

Revenue: $42.0B in 2023

Abbott Laboratories (Abbott) is a health care and medical device corporation that develops, creates, produces, and markets goods. Products related to gastroenterology, women's health, cardiovascular and metabolic, pain and central nervous system, respiratory drugs and vaccines, biosimilars, core laboratory and transfusion medicine systems, point-of-care systems, rapid diagnostics lateral flow testing, informatics and automation solutions, nutritional products, rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products, and neuromodulation products are among its primary offerings. The business sells its goods to consumers in North America, Latin America, the Middle East, Europe, Asia-Pacific, and Africa through distributors, wholesalers, government organizations, hospitals, pharmacies, and independent merchants. The US headquarters of Abbott are located in Abbott Park, Illinois.

LivaNova PLC

Establishment: 2015

Headquarters: United Kingdom

Website: www.livanova.com

Revenue: $1.2B in 2023

Medical technology business LivaNova PLC (LivaNova) sells equipment for neuromodulation and heart surgery. The company's neuromodulation products include an implanted vagus nerve stimulation therapy system for individuals with heart failure, depression, treatment-resistant epilepsy, and other chronic conditions. Oxygenators, heart-lung machines, perfusion tubing systems, cannulae, and accessories are among the goods it offers for cardiovascular surgery. Other products include autotransfusion and autologous blood cleaning systems, as well as perfusion charting systems. Patients, medical professionals, and healthcare systems may all benefit from the company's solutions. The UK's London, Greater London, is home to LivaNova's headquarters.